Ruggaard & Associates LLC lifted its holdings in Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The fund owned 49,908 shares of the company’s stock after buying an additional 3,585 shares during the quarter. Columbia Research Enhanced Value ETF makes up 0.5% of Ruggaard & Associates LLC’s holdings, making the stock its 23rd largest holding. Ruggaard & Associates LLC’s holdings in Columbia Research Enhanced Value ETF were worth $1,234,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in REVS. Commonwealth Equity Services LLC acquired a new position in Columbia Research Enhanced Value ETF in the fourth quarter valued at approximately $204,000. Pine Valley Investments Ltd Liability Co grew its position in shares of Columbia Research Enhanced Value ETF by 2.5% in the third quarter. Pine Valley Investments Ltd Liability Co now owns 28,472 shares of the company’s stock valued at $723,000 after purchasing an additional 700 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in Columbia Research Enhanced Value ETF during the 4th quarter worth approximately $954,000.
Columbia Research Enhanced Value ETF Stock Down 5.7 %
Shares of REVS opened at $22.67 on Friday. The firm’s fifty day moving average is $25.41 and its two-hundred day moving average is $25.57. The stock has a market cap of $58.94 million, a PE ratio of 17.30 and a beta of 0.83. Columbia Research Enhanced Value ETF has a 52-week low of $22.56 and a 52-week high of $27.03.
About Columbia Research Enhanced Value ETF
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Further Reading
- Five stocks we like better than Columbia Research Enhanced Value ETF
- What Investors Need to Know to Beat the Market
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Why Are Stock Sectors Important to Successful Investing?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What is a Dividend King?
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
